Do patients with neutropenic fever and Methicillin-sensitive Staphylococcus aureus (MSSA) positive nasal swab, undergoing chemotherapy, require contact precautions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Contact precautions are not typically required for a patient on chemotherapy with neutropenic fever and a positive nasal swab for methicillin-sensitive Staphylococcus aureus (MSSA), but standard precautions should be strictly followed. These include hand hygiene before and after patient contact, use of personal protective equipment (PPE) when there's a risk of exposure to body fluids, and proper handling of potentially contaminated equipment or surfaces 1. The patient should be placed in a private room if possible, and visitors should be limited. Healthcare workers should pay extra attention to hand hygiene and avoid entering the room if they have any signs of infection. While MSSA colonization doesn't necessitate contact precautions, the patient's neutropenic status makes them highly susceptible to infections. Therefore, meticulous adherence to infection control practices is crucial, as emphasized in guidelines for preventing nosocomial infections 1. It's also important to consider the patient's overall clinical condition and the risk of developing severe infections, and to provide broad-spectrum antimicrobial coverage if necessary, as recommended in guidelines for the diagnosis and management of skin and soft tissue infections 1.

Some key considerations for infection control in this setting include:

  • Implementation of a robust infection control program, including monitoring for MRSA colonization and infection 1
  • Use of contact precautions for patients with MRSA colonization or infection, but not typically for MSSA colonization 1
  • Proper cleaning and disinfection of equipment and the environment 1
  • Education of healthcare workers, patients, and their families about infection control practices 1
  • Consideration of the patient's individual risk factors for infection, such as neutropenia and immunocompromised status, and adjustment of infection control measures accordingly 1

From the Research

Infection Management in Immunocompromised Patients

  • The management of infections in immunocompromised patients, including those with neutropenic fever, is crucial for their survival and quality of life 2, 3.
  • Neutropenic fever is a common complication in patients undergoing chemotherapy, and prompt recognition and treatment are essential to prevent severe outcomes 3, 4.

Contact Precautions for MSSA Positive Nasal Swab

  • There is limited evidence to suggest that contact precautions are necessary for patients with MSSA positive nasal swab, especially if they are not showing symptoms of infection 5.
  • The use of contact isolation precautions has been associated with negative outcomes, including increased risk of pneumonia and urinary tract infections, and its use should be carefully evaluated 5.

Chemotherapy-Induced Neutropenia and Infection Risk

  • Chemotherapy-induced neutropenia increases the risk of infection, and patients with neutropenic fever require prompt and effective treatment 6, 4.
  • The management of neutropenic fever involves the use of empiric antibiotic therapy, and the choice of antibiotics should be guided by the patient's clinical presentation and risk factors 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Management of infection in immunocompromised patients].

Deutsche medizinische Wochenschrift (1946), 2022

Research

Fever in immunocompromised hosts.

Emergency medicine clinics of North America, 2013

Research

Management of chemotherapy-induced neutropenic fever.

Hospital practice (1995), 2013

Research

Neutropenia Precautions for Children Receiving Chemotherapy or Stem Cell Transplantation for Cancer.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.